Open Letter on Seralini “Retraction” and Pledge to Boycott Pro-Biotech Science Journal Publisher Elsevier
re: "Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize," by GE Seralini et al, published in Food and Chemical Toxicology 2012, 50(11), 4221-31...
December 4, 2013 | Source: Institute of Science in Society | by
For related articles and more information, please visit OCA’s Genetic Engineering page and our Millions Against Monsanto page.
This letter has been signed by 716 scientists and 1927 non-scientists from 73 different countries – add your name
To:
Wallace Hayes Editor in Chief Food and Chemical Toxicology (FCT)
Cc
Elsevier
re: “Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize,” by GE Seralini et al, published in Food and Chemical Toxicology 2012, 50(11), 4221-31
Your decision to retract the paper is in clear violation of the international ethical norms as laid down by the Committee on Publication Ethics (COPE), of which FCT is a member. According to COPE, the only grounds for retraction are (1) clear evidence that the findings are unreliable due to misconduct or honest error, (2) plagiarism or redundant publication, or (3) unethical research. You have already acknowledged that the paper of Seralini et al (2012) contains none of those faults.
This arbitrary, groundless retraction of a published, thoroughly peer-reviewed paper is without precedent in the history of scientific publishing, and raises grave concerns over the integrity and impartiality of science. These concerns are heightened by a sequence of events surrounding the retraction:
The retraction is erasing from the public record results that are potentially of very great importance for public health. It is censorship of scientific research, knowledge, and understanding, an abuse of science striking at the very heart of science and democracy, and science for the public good.
We urge you to reverse this appalling decision, and further, to issue a fulsome public apology to Seralini and his colleagues. Until you accede to our request, we will boycott Elsevier, i.e., decline to purchase Elsevier products, to publish, review, or do editorial work for Elsevier.